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YloQ is a putative ATP/GTP-binding protein of unknown function
identi®ed from the complete sequence of the Bacillus subtilis genome.
A gene-knockout programme established that yloQ is one of a set of
some 270 indispensable genes for the viability of this organism.
Crystals of YloQ have been grown from HEPES-buffered solutions
at pH 7.5 containing polyethylene glycol and diffraction data have
been collected extending to 2.5 AÊ spacing.
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1. Introduction
The genome of Bacillus subtilis contains
around 4100 genes, of which some 270 have
either been shown to be or predicted to be
essential (Kunst et al., 1997; Kobayashi et al.,
2003). Out of this group of genes, 11 have
unknown roles in the physiology of the cell.
YloQ, a polypeptide of 298 residues, is one
such protein. Although it has not been possible
to generate strains harbouring deletions in
yloQ, low-level expression of this gene
(together with the downstream genes yloR and
yloS) is associated with morphological changes
in which the cells have a more spherical shape
(E. Madec & S. J. SeÂror, unpublished results).
YloQ contains motifs characteristic of a GTP-
binding site, including the G1 (Walker A), G3
(Walker B) and G4 signature sequences. The
order in which these motifs appear in the
sequence of YloQ indicates a circular permu-
tation of a classical GTPase, the G1±G3±G4
motifs appearing in the order G4±G1±G3.
Another protein that exhibits this permutation
is YjeQ from Escherichia coli, the function of
which is also unknown (Leipe et al., 2002;
Daigle et al., 2002). It has been con®rmed that
YloQ is a GTP-binding protein with a low
intrinsic GTPase activity that is abolished by
a mutation in the Walker A motif (CladieÁ re
et al., in preparation). YloQ, like YjeQ, also
possesses a putative zinc-binding site as
deduced from the presence of a Cys-X4-Cys-X-
His-X5-Cys motif towards its C-terminus.
To provide a structural description of this
curious GTPase, we have overexpressed,
puri®ed and crystallized YloQ from B. subtilis
and collected preliminary diffraction data from
these crystals. It is hoped that combined with
biochemical and genetic analyses, the structure
of YloQ will de®ne the essential function of
this protein and illuminate its contribution to
cell physiology.
2. Expression and purification
YloQ was produced as an N-terminally hexa-
histidine-tagged protein from E. coli DH5
harbouring pOMG201, a pBAD plasmid
derivative in which expression of the recom-
binant protein is driven by the arabinose-
inducible pBAD promoter. Cells were grown
in LB medium supplemented with ampicillin at
310 K to OD600 = 1.5. Expression of recombi-
nant His6-YloQ was induced by the addition of
arabinose to a ®nal concentration of 0.05%.
Cells were subsequently lysed, the cell extract
loaded onto a nickel-chelation column equili-
brated with 20 mM imidazole and the His-
tagged YloQ was eluted with a 20±300 mM
imidazole gradient. The wild-type protein,
which was >90% pure, was identi®ed by its size
and its GTPase activity, whereas the matching
peak fraction from cells overexpressing a
catalytic site mutation in YloQ was completely
inactive (CladieÁ re et al., in preparation).
Column fractions were analysed by sodium
dodecyl sulfate±polyacrylamide gel electro-
phoresis (SDS±PAGE) and those containing
YloQ were identi®ed and pooled. The YloQ
sample was concentrated by ultra®ltration in
an Amicon cell and loaded onto a Superdex
S200 (120 ml, Pharmacia) gel-®ltration column
equilibrated with 30 mM HEPES buffer
pH 7.5, 100 mM NaCl. The gel-®ltration
pro®les suggest that YloQ is present as a
mixture of monomers and dimers, a conclusion
that was con®rmed by analytical ultra-
centrifugation analysis (CladieÁ re et al., in
preparation). This two-step puri®cation
procedure yielded 65 mg of pure (97% as
judged by SDS±PAGE) His6-tagged YloQ
suitable for crystallization trials from 2 l of
culture grown in a fermentor. YloQ was
concentrated to 15±25 mg mlÿ1 in 30 mM
HEPES pH 7.5, 100 mM NaCl and stored as
frozen aliquots at 193 K.
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3. Crystallization
Crystallization experiments with His6-
tagged YloQ were set up at 291 K using the
hanging-drop vapour-diffusion method
exploiting a variety of screening kits
(Brzozowski & Walton, 2001; Jancarik &
Kim, 1991). Initial crystals of YloQ
appeared from CSS-I condition No. 6 and
CSS-II condition No. 6. The conditions were
re®ned by varying the PEG concentrations
and sizes until small single crystals (0.2 0.2
 0.1 mm) were obtained from hanging
drops consisting of 1 ml of 10±15 mg mlÿ1
protein and an equal volume of either (a)
0.1 M HEPES pH 7.5, 0.2 M calcium acetate
and 10±14% polyethylene glycol 5000 or (b)
0.1 M HEPES pH 7.5, 0.8 M sodium formate
and 22% polyethylene glycol 2000 (Fig. 1).
These crystals were obtained with pooled
protein containing the monomer and dimer
fractions following gel-®ltration chromato-
graphy. Curiously, attempts to grow crystals
from the separate monomer and dimer
fractions have so far been unsuccessful.
Crystals of YloQ have also been grown in
the presence of the non-hydrolysable GTP
analogue GTPS. These crystals grew under
the same conditions as those of the native
protein; however, they have a different
needle-like morphology, perhaps indicating
that the nucleotide is bound. As yet these
crystals are unsuitable for X-ray analysis.
4. Data collection
A single crystal grown under condition (a)
above was transferred into a solution of
mother liquor supplemented with 25%
glycerol and ¯ash-cooled in liquid N2. The
crystal was exposed to synchrotron radiation
on beamline BM14 at the ESRF, Grenoble
( = 0.9184 AÊ ) and diffraction data were
recorded on a MAR CCD detector. A
complete three-dimensional data set
extending to 2.5 AÊ spacing was recorded in
360 exposures with a 0.5 oscillation. The
exposure time was 25 s and the total data-
acquisition time was 2.5 h. The data were
processed using DENZO, SCALEPACK
and TRUNCATE (Otwinowski & Minor,
1997; Collaborative Computational Project,
Number 4, 1994). The crystals belong to
space group P4(1/3)212, with unit-cell para-
meters a = b = 47.9, c = 274.2 AÊ , and have a
mosaicity of 0.5. If there is assumed to be a
single YloQ protomer in the asymmetric
unit, the solvent content is 46.3% and the
Matthews coef®cient is 2.3 AÊ 3 Daÿ1. 220 313
observations of 11 888 re¯ections in the
resolution range 25±2.5 AÊ were measured
(286 observations of 83 re¯ections were
rejected during scaling). The mean overall
redundancy is 6.1 (5.4); ®gures in paren-
theses represent the highest resolution shell
(2.59±2.50 AÊ ). The data are 99.9% (99.7%)
complete with an overall Rmerge (on inten-
sities) of 0.091 (0.268); the mean I/(I) is
12.9 (5.5) and the percentage of re¯ections
for which I/(I) > 3 is 85.2 (66.8). A subse-
quent resolution test suggested that the
crystals diffract to 2.2 AÊ spacing.
5. Discussion
Crystals of YloQ suitable for structure
determination have been grown and efforts
are currently under way to determine
suitable phases for this purpose. Attempts to
determine the structure of YloQ by mole-
cular replacement using the coordinates of
the Era (Chen et al., 1999) translation factor
and GTPase (the two proteins have 37
identical and 63 conserved residues over
300 residues) as a search model have
proved unsuccessful and ab initio phases are
sought. We are therefore (i) preparing
SeMet-substituted YloQ for crystallization
and (ii) screening for conventional deriva-
tives of the existing crystals by soaking in
solutions containing heavy-atom compounds,
to enable phases to be derived by anomalous
dispersion and/or multiple isomorphous
replacement methods, respectively.
YloQ is indispensable to B. subtilis and it
is very likely to be essential in other Gram-
positive organisms including pathogens. In
B. subtilis, the gene encoding YloQ is situ-
ated immediately downstream of the genes
prpC and prkC which encode a protein
phosphatase (Obuchowski et al., 2000) and a
protein kinase (Madec et al., 2002, 2003),
respectively. The prpC-prkC-yloQ gene
arrangement is conserved in several Gram-
positive species, including B. anthracis,
Listeria monocytogenes and Staphylococcus
aureus, and prkC has been shown to be
essential in the latter (Forsyth et al., 2002).
These observations indicate that YloQ is a
promising target for the design of drugs
targeted against Gram-positive pathogenic
bacteria. A three-dimensional structure of
the protein will underpin this effort.
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Figure 1
Crystals of YloQ grown from (a) 0.1 M HEPES pH 7.5, 0.2 M calcium acetate and 10±14% polyethylene glycol
5000 and (b) 0.1 M HEPES pH 7.5, 0.8 M sodium formate and 22% polyethylene glycol 2000. The width of these
panels corresponds to 1 mm.
